|
Orthologous residues
|
|
PDGFRb (human): Y771‑p, PDGFRb (mouse): Y770‑p, PDGFRb (rat): Y770‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
PAE (endothelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
pig
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
PHOSPHATASE
|
SHP-2 (human)
|
co-immunoprecipitation
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
PDGF
|
|
|
|
increase
|
|
|
vanadate
|
PDGF
|
|
|
augment treatment-induced increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
RASA1 (human)
|
|
Induces
|
|
|
|
|